Reported Standalone quarterly numbers for Chankya Investments are: Net Sales at Rs 14.84 crore in September 2024 up 604.59% from Rs. 2.11 crore in September 2023. Quarterly Net Profit at Rs. 0.20 crore in September 2024 up 1614.29% from Rs. 0.01 crore in September 2023. EBITDA stands at Rs. 0.28 crore in September 2024 up 1300% from Rs. 0.02 crore in September 2023.

Reported Standalone quarterly numbers for Airan are: Net Sales at Rs 22.81 crore in September 2024 down 3.14% from Rs. 23.55 crore in September 2023. Quarterly Net Loss at Rs. 2.64 crore in September 2024 down 191.93% from Rs. 2.87 crore in September 2023. EBITDA stands negative at Rs. 0.14 crore in September 2024 down 103.08% from Rs. 4.55 crore in September 2023.

Reported Standalone quarterly numbers for Shree Salasar Investments are: Net Sales at Rs 0.32 crore in September 2024 down 28.21% from Rs. 0.45 crore in September 2023. Quarterly Net Profit at Rs. 0.22 crore in September 2024 down 42.56% from Rs. 0.39 crore in September 2023. EBITDA stands at Rs. 0.26 crore in September 2024 down 36.59% from Rs. 0.41 crore in September 2023.

Transport Corporation of India maintained double-digit growth in 1HFY25, with total revenue up 11% YoY, driven by growth across business segments. The supply chain and freight divisions are expected to maintain double-digit growth, driven by stable demand in the auto industry and a shift from the unorganized sector.

Adani Enterprises Ltd. and Wilmar International Ltd. are considering delaying a proposed sale of at least 12% in their Indian food venture after a US bribery indictment against the billionaire-founder Gautam Adani, according to people familiar with the matter. Adani Wilmar Ltd., an equal joint venture between India’s Adani Group and the Singapore-based commodity trader, was slated to start.

Reported Standalone quarterly numbers for Jindal Poly Investment and Finance Company are: Net Sales at Rs 7.90 crore in September 2024 up 5.86% from Rs. 7.46 crore in September 2023. Quarterly Net Profit at Rs. 6.71 crore in September 2024 up 6.23% from Rs. 6.32 crore in September 2023. EBITDA stands at Rs. 7.80 crore in September 2024 up 5.69% from Rs. 7.38 crore in September 2023.

Reported Standalone quarterly numbers for Zodiac Ventures are: Net Sales at Rs 0.59 crore in September 2024 up 0.02% from Rs. 0.59 crore in September 2023. Quarterly Net Profit at Rs. 0.44 crore in September 2024 down 11.69% from Rs. 0.50 crore in September 2023. EBITDA stands at Rs. 1.03 crore in September 2024 up 33.77% from Rs. 0.77 crore in September 2023.

Apollo Hospitals Enterprises is set to drive growth through its online platform, launching insurance products and a concierge service, which will boost GMV and margins. The company plans to add 2,860 beds and ~570 Apollo 24/7 stores, expanding comprehensive healthcare services. With a target price of INR8,020, the stock is reiterated as a BUY.

Reported Standalone quarterly numbers for Maha Rashtra Apex Corporation are: Net Sales at Rs 0.05 crore in September 2024 down 96.98% from Rs. 1.68 crore in September 2023. Quarterly Net Profit at Rs. 0.12 crore in September 2024 down 93.46% from Rs. 1.89 crore in September 2023. EBITDA stands negative at Rs. 0.27 crore in September 2024 down 121.09% from Rs. 1.28 crore in September 2023.

Reported Standalone quarterly numbers for Universal Autofoundry are: Net Sales at Rs 49.83 crore in September 2024 down 4.7% from Rs. 52.28 crore in September 2023. Quarterly Net Profit at Rs. 0.94 crore in September 2024 down 16.98% from Rs. 1.13 crore in September 2023. EBITDA stands at Rs. 4.91 crore in September 2024 up 34.15% from Rs. 3.66 crore in September 2023.

Dixon Technologies is expected to maintain healthy growth and margins beyond the Production-Linked Incentive (PLI) scheme ending in FY26, driven by client additions, improved wallet share, and export opportunities in the mobile segment, with backward integration supporting margins and scale-up in other segments.

Reported Standalone quarterly numbers for Taparia Tools are: Net Sales at Rs 224.00 crore in September 2024 up 7.15% from Rs. 209.06 crore in September 2023. Quarterly Net Profit at Rs. 30.76 crore in September 2024 up 30.05% from Rs. 23.65 crore in September 2023. EBITDA stands at Rs. 41.83 crore in September 2024 up 27.76% from Rs. 32.74 crore in September 2023.

Reported Standalone quarterly numbers for Alicon Castalloy are: Net Sales at Rs 412.43 crore in September 2024 up 15.04% from Rs. 358.51 crore in September 2023. Quarterly Net Profit at Rs. 14.44 crore in September 2024 up 10.84% from Rs. 13.03 crore in September 2023. EBITDA stands at Rs. 51.63 crore in September 2024 up 17.88% from Rs. 43.80 crore in September 2023.

The Nifty Realty index is up another 1% in Tuesday's trading session, extending its gain for the seventh day running. With today's move, the index has rallied over 45% from its 52-week low of 717.30. For today's session, five out of the 10-pack index constituents are trading with gains. Stocks like Phoenix Mills and Godrej Properties have gained up to 15% during the last seven trading sessions.

Shilpa Medicare on Tuesday, November 26, said the Subject Expert Committee (Haematology) has given its approval to conduct Phase III clinical trials for the Recombinant Human Albumin (rHA) 20%. Shilpa Medicare's Recombinant Human Albumin 20% (rHA) is derived from yeast and offers a highly purified, structurally and functionally equivalent alternative to human serum albumin, the company said.